Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the ...

Idorsia Pharmaceuticals, US Inc. today announced that QUVIVIQ™ (daridorexant) CIV 25 mg and 50 mg tablets are now commercially available for adult patients with insomnia, which is characterized ...

Idorsia's insomnia treatment Quviviq was approved by the FDA last year and endorsed by actress Jennifer Aniston and Olympic skier Lindsey Vonn. Swiss firm with Radnor operations gets FDA approval ...

Based in Allschwil, Switzerland, Idorsia has its U.S. operations — Idorsia Pharmaceuticals USA — in Radnor, where the company employs about 125 workers. Idorsia, which has about 1,100 ...

Push to remove a newer class of insomnia drugs from the controlled substance list based on data demonstrating negligible potential for abuse Sponsored by Idorsia Pharmaceuticals David, a retired ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

Ad hoc announcement pursuant to Art. 53 LR Bondholder meetings will take place on Wednesday, June 25, 2025, to vote on proposals to amend the terms of the two outstanding convertible bonds CB 2025 ...

RADNOR, PA — Idorsia Pharmaceuticals U.S. Inc. has announced the availability of TRYVIO™ (aprocitentan) in the United States for adults suffering from hypertension. This new medication is ...

Idorsia Pharmaceuticals plans for widespread availability in the US by the second half of 2024 to benefit the millions of patients who cannot control their hypertension with other drugs.

Idorsia Pharmaceuticals US partnered with Ruder Finn on a feature-length documentary, narrated by Octavia Spencer, about the human toll of insomnia and the science of sleep. The film premiered on ...

Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the company to ensure a smooth transition Allschwil, Switzerland - June 10 ...